Precision Business Insights has published a report on the global cancer gene therapy market, estimating its value at USD 4,153.6 Million in 2025 and is expected to expand at a compound annual growth rate (CAGR) of 24.3% over the forecast period 2026-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/global-cancer-gene-therapy-market

Market Definition:

Cancer gene therapy is a cutting-edge therapeutic strategy that fights or prevents cancer by changing the genetic material in a patient's cells. This method seeks to improve the body's innate capacity to recognize and eliminate cancer cells, replace or repair damaged genes, or introduce new genes to aid in the fight against cancer. Please don't hesitate to inquire for more information about particular techniques or recent developments in cancer gene therapy.

Drivers:

1) Rising Global Cancer Burden.
2) Advancements in Gene Editing Technology.

The global cancer gene therapy market segmentation:

1) By Therapy Type: Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer.
2) By End-User: Hospitals and Clinics, Biopharma and Biotechnology Companies, Academic and Research Institutes, Others.

Regional Overview:
The report also examines the current concerns and their Future Effects on the cancer gene therapy market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the cancer gene therapy market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

·         North America (U.S., Canada)

·         Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

·         Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)

·         Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)

·         Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

The competitive landscape is dominated by major players like Novartis → Gilead/Kite Pharma → Bristol-Myers Squibb → CRISPR Therapeutics → Editas Medicine → Intellia Therapeutics → Adaptimmune Therapeutics → bluebird bio → Mustang Bio → Pfizer → Amgen → Merck & Co. → GlaxoSmithKline → Sarepta Therapeutics → uniQure → Oncorus → Tmunity Therapeutics → Legend Biotech → Allogene Therapeutics → Carisma Therapeutics → Celyad Oncology → MaxCyte → Precision BioSciences → TxCell → Poseida Therapeutics → Codiak BioSciences → Sangamo Therapeutics → Beam Therapeutics → Astellas Pharma → Johnson & Johnson (JNJ) → Roche → Daiichi Sankyo → Takeda → AstraZeneca → Moderna Therapeutics → BioNTech → Vaccibody → Immunocore → Nektar Therapeutics → Iovance Biotherapeutics → Akeso Biopharma → Hutchmed → Shanghai Sunway Biotech → Fosun Kite Biotech → GenScript ProBio → Can-Bridge Life Sciences

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747